Cargando…

Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review

Minimally invasive surgical techniques, including laparoscopic and robotic-assisted radical cystectomy (RC), are emerging as the preferred treatment options for invasive bladder cancer. Mounting evidence has demonstrated that laparoscopic and robotic-assisted RC with extended pelvic lymph node disse...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Weijun, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bladder 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627080/
https://www.ncbi.nlm.nih.gov/pubmed/37936583
http://dx.doi.org/10.14440/bladder.2023.849
_version_ 1785131466933403648
author Fu, Weijun
Zhang, Xu
author_facet Fu, Weijun
Zhang, Xu
author_sort Fu, Weijun
collection PubMed
description Minimally invasive surgical techniques, including laparoscopic and robotic-assisted radical cystectomy (RC), are emerging as the preferred treatment options for invasive bladder cancer. Mounting evidence has demonstrated that laparoscopic and robotic-assisted RC with extended pelvic lymph node dissection (PLND) is a viable alternative for managing invasive bladder cancer. In this review, we summarized recent advances and critically assessed the minimally invasive approaches and risk factors associated with extended PLND in patients undergoing laparoscopic or robotic-assisted RC. The findings indicated that laparoscopic and robotic-assisted PLND, employing either a standard or extended approach, is technically feasible and offers benefits such as minimal invasiveness, superior visualization, reduced blood loss, and expedited recovery. The risk factors involved in the laparoscopic extended PLND are minimal. Clinically, laparoscopic and robotic-assisted extended PLND is significantly advantageous in that it sticks to the principles of open surgery and respects anatomical boundaries. Nevertheless, laparoscopic and robotic-assisted extended PLND is technically challenging and necessitate extended operation time. Furthermore, large-scale, prospective, multicenter trials are warranted to validate the long-term efficacy of laparoscopic and robotic-assisted extended PLND in terms of disease-specific survival.
format Online
Article
Text
id pubmed-10627080
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bladder
record_format MEDLINE/PubMed
spelling pubmed-106270802023-11-07 Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review Fu, Weijun Zhang, Xu Bladder (San Franc) Review Minimally invasive surgical techniques, including laparoscopic and robotic-assisted radical cystectomy (RC), are emerging as the preferred treatment options for invasive bladder cancer. Mounting evidence has demonstrated that laparoscopic and robotic-assisted RC with extended pelvic lymph node dissection (PLND) is a viable alternative for managing invasive bladder cancer. In this review, we summarized recent advances and critically assessed the minimally invasive approaches and risk factors associated with extended PLND in patients undergoing laparoscopic or robotic-assisted RC. The findings indicated that laparoscopic and robotic-assisted PLND, employing either a standard or extended approach, is technically feasible and offers benefits such as minimal invasiveness, superior visualization, reduced blood loss, and expedited recovery. The risk factors involved in the laparoscopic extended PLND are minimal. Clinically, laparoscopic and robotic-assisted extended PLND is significantly advantageous in that it sticks to the principles of open surgery and respects anatomical boundaries. Nevertheless, laparoscopic and robotic-assisted extended PLND is technically challenging and necessitate extended operation time. Furthermore, large-scale, prospective, multicenter trials are warranted to validate the long-term efficacy of laparoscopic and robotic-assisted extended PLND in terms of disease-specific survival. Bladder 2023-05-31 /pmc/articles/PMC10627080/ /pubmed/37936583 http://dx.doi.org/10.14440/bladder.2023.849 Text en © 2013-2023 Bladder, All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License: http://creativecommons.org/licenses/by-nc-sa/4.0
spellingShingle Review
Fu, Weijun
Zhang, Xu
Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title_full Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title_fullStr Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title_full_unstemmed Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title_short Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review
title_sort laparoscopic and robotic-assisted extended pelvic lymph node dissection for invasive bladder cancer: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627080/
https://www.ncbi.nlm.nih.gov/pubmed/37936583
http://dx.doi.org/10.14440/bladder.2023.849
work_keys_str_mv AT fuweijun laparoscopicandroboticassistedextendedpelviclymphnodedissectionforinvasivebladdercancerareview
AT zhangxu laparoscopicandroboticassistedextendedpelviclymphnodedissectionforinvasivebladdercancerareview